Sign In
Buy GBT
$68.49
+0 (+0%)
At Close: Jan 27, 2023
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
08:00am, Friday, 05'th Aug 2022 Benzinga
U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session.
ChemoCentryx, Inc. (NASDAQ: CCXI)
Codiak BioSciences, Inc. (CDAK) Reports Q2 Loss, Tops Revenue Estimates
09:15pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Codiak BioSciences, Inc. (CDAK) delivered earnings and revenue surprises of 61.54% and 701.52%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stoc
Why Global Blood Therapeutics Stock Is Soaring Today
06:42pm, Thursday, 04'th Aug 2022 The Motley Fool
A buyout rumor is powering the biotech's shares higher.
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
05:12pm, Thursday, 04'th Aug 2022 Benzinga
Gainers
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.
Onion Global Limited (NYSE: OG) gained 113.9% to $0.8556.
ChemoCentryx,
Why Global Blood Therapeutics Stock Is Soaring Today
02:42pm, Thursday, 04'th Aug 2022
A buyout rumor is powering the biotech's shares higher.
Alibaba, MercadoLibre And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
11:59am, Thursday, 04'th Aug 2022 Benzinga
Global Blood Therapeutics, Inc. (NASDAQ: GBT) rose 19.3% to $40.47 in pre-market trading following a report suggesting the company is attracting takeover interest. According to a Bloomberg report, cit
Why Is Yellow Trading Higher By 33%: Here Are 48 Stocks Moving Premarket
10:51am, Thursday, 04'th Aug 2022 Benzinga
Gainers
Missfresh Limited (NASDAQ: MF) shares rose 112.9% to $0.2450 in pre-market trading after dropping 7% on Wednesday.
GreenLight Biosciences Holdings (NASDAQ: GRNA) shares rose 100.6% to $6.54 i
Global Blood Therapeutics shares jump 34% after Bloomberg report about 'takeover interest'
09:07am, Thursday, 04'th Aug 2022
Shares of Global Blood Therapeutics Inc. GBT, +3.04% were up 34.4% in premarket trading on Thursday after Bloomberg reported that the company is "attracting takeover interest," citing people familiar
Why Global Blood Therapeutics Stock Is Surging After Hours
10:17pm, Wednesday, 03'rd Aug 2022 Benzinga
Global Blood Therapeutics Inc (NASDAQ: GBT) shares are soaring in Wednesday's after-hours session following a report suggesting the company is attracting takeover interest.
According to a Bloomberg r
GBT Announces Participation at the Wedbush PacGrow Healthcare Conference
08:05pm, Wednesday, 03'rd Aug 2022 GlobeNewswire Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will participate in a virtual fireside chat at the Wedbush
Analysts Estimate Regeneron (REGN) to Report a Decline in Earnings: What to Look Out for
02:01pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Regeneron (REGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Global Blood Therapeutics (GBT) Q2 Earnings Expected to Decline
02:01pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
Global Blood (GBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Global Blood Therapeutics (GBT) Q2 Earnings Expected to Decline
11:40am, Tuesday, 26'th Jul 2022
Global Blood (GBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MHRA Grants Marketing Authorization for GBT’s Oxbryta® (voxelotor) for Use in Great Britain for the Treatment of Hemolytic Anemia in Patients with Sickle Cell Disease Age 12 Years and Older
07:01am, Tuesday, 26'th Jul 2022 GlobeNewswire Inc.
Voxelotor is the first medicine approved in Great Britain to directly inhibit sickle hemoglobin (HbS) polymerization, the underlying molecular cause of sickle cell disease Voxelotor is the first medic
GUERBET : Chiffre d’affaires au 30 juin 2022
03:45pm, Thursday, 21'st Jul 2022 GlobeNewswire Inc.
Chiffre d’affaires du 1er semestre 2022
